Invest in PROCEPT BioRobotics Corp on Stash
PROCEPT BioRobotics Corporation is a United States-based surgical robotics company. The Company enables patient care by developing transformative solutions in urology. The Company has developed Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH). It has developed a surgical robot, Aquabeam that provides autonomous tissue removal from enlarged prostate to treat BPH. Aquabeam provides multi-dimensional imaging, personalized treatment planning, and heat-free waterjet with autonomous robotic execution.
Ticker: PRCT
PROCEPT BioRobotics Corp
$31.68
+11.55%
$
PRCT Performance Breakdown
Share Price
$31.68
Today's change
-1.83%
Year to date change (YTD)
-61.9%
Dividend yield
0.0
Last dividend paid
N/A
Last dividend pay date
N/A
About PRCT
PROCEPT BioRobotics Corporation is a United States-based surgical robotics company. The Company enables patient care by developing transformative solutions in urology. The Company has developed Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH). It has developed a surgical robot, Aquabeam that provides autonomous tissue removal from enlarged prostate to treat BPH. Aquabeam provides multi-dimensional imaging, personalized treatment planning, and heat-free waterjet with autonomous robotic execution.
PROCEPT BioRobotics Corp Stock Ticker
PRCT
For more information
Invest in PROCEPT BioRobotics Corp on Stash
PROCEPT BioRobotics Corporation is a United States-based surgical robotics company. The Company enables patient care by developing transformative solutions in urology. The Company has developed Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH). It has developed a surgical robot, Aquabeam that provides autonomous tissue removal from enlarged prostate to treat BPH. Aquabeam provides multi-dimensional imaging, personalized treatment planning, and heat-free waterjet with autonomous robotic execution.
Certain companies are volatile
Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.
PROCEPT BioRobotics Corp stock news
Why invest with Stash?
Fractional shares
Thousands of stocks and ETFs. No investing minimums.
Unlimited trades
Plus no add-on trading commission fees.†
Diversification analysis
Custom investment recommendations can help you diversify.
Automatic investing
Dividend reinvestment,8 recurring investments, and more.
The Stock-Back® Card
We’ll give you matching stock in companies you shop at.1
Learn how to invest
Get professional advice and education at every step.
How to buy PROCEPT BioRobotics Corp stock on Stash
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Stash offers two subscription plans: Stash Growth and Stash+.
Once your market order of PROCEPT BioRobotics Corp stock is complete, you'll officially be a shareholder of PROCEPT BioRobotics Corp!
Invest in PROCEPT BioRobotics Corp on Stash
PROCEPT BioRobotics Corporation is a United States-based surgical robotics company. The Company enables patient care by developing transformative solutions in urology. The Company has developed Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH). It has developed a surgical robot, Aquabeam that provides autonomous tissue removal from enlarged prostate to treat BPH. Aquabeam provides multi-dimensional imaging, personalized treatment planning, and heat-free waterjet with autonomous robotic execution.
More Health Care stocks
Zynex, Inc.
115.62%
Verrica Pharmaceuticals Inc
31.05%
Arrowhead Pharmaceuticals Inc
23.34%
Ironwood Pharmaceuticals Inc
23.32%
Sana Biotechnology Inc
14.53%
Sangamo Therapeutics, Inc.
11.8%
Anavex Life Sciences Corp
11.56%
Cassava Sciences Inc
11.51%
Tenaya Therapeutics Inc
10.57%
Repro Med Systems Inc
10.48%
Valneva SE
9.15%



